SCHEMBL11947340

SCHEMBL11947340

COC(=O)c1ccc(-c2cc(C)c(Oc3nc(Nc4ccc(N)cc4)nc4[nH]cnc34)c(C)c2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 3/20 0.46
▸ CYP2C19 P33261 3/20 0.46
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ KCNH2 Q12809 2/20 0.35
▸ ABCC3 O15438 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ ABCC1 P33527 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ ABCC2 Q92887 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10256560 0.92 CYP2C9 (0.44) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL4105715 0.90 CYP2C9 (0.57) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL4110903 0.83 CYP2C9 (0.57) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL13561269 0.82 CYP2C9 (0.56) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL13798618 0.81 CDK2 (0.45) CYP2C9CYP2C19KDM4EHPGDKMT2A
SCHEMBL10255552 0.80 CYP2C9 (0.40) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL10255242 0.80 CYP2C9 (0.40) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL11936696 0.79 KMT2A (0.50) CYP2C9CYP2C19KDM4EMEN1HPGD
SCHEMBL11947999 0.78 CDK2 (0.39) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2
SCHEMBL13561268 0.78 CYP2C9 (0.55) CYP2C9CYP2C19CYP3A4CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220091-B1 REVERSE TRANSCRIPTASE INHIBITORS ARDEA BIOSCIENCES INC (US) 2012-07-25 — — EP disclosed
Send feedback